Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Invasive diagnosis of pulmonary hypertension and its effects on the right heart].

Deutsche medizinische Wochenschrift (1946)·2006
Same author

[Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].

Deutsche medizinische Wochenschrift (1946)·2006
Same author

Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial.

British journal of cancer·2006
Same author

Non-pigmentary actions of alpha-melanocyte-stimulating hormone--lessons from the cutaneous melanocortin system.

Cellular and molecular biology (Noisy-le-Grand, France)·2006
Same author

Soliton-radiation beat analysis.

Physical review. E, Statistical, nonlinear, and soft matter physics·2006
Same author

[Radionuclide bone scan in patients with newly diagnosed prostate cancer. Clinical aspects and cost analysis].

Der Urologe. Ausg. A·2006

Related Experiment Video

Updated: Jun 12, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

[Alpha-melanocyte-stimulating hormone. From bench to bedside].

M Böhm1, T A Luger

  • 1Klinik und Poliklinik für Hautkrankheiten-Allgemeine Dermatologie und Venerologie, Universitätsklinikum Münster, Von-Esmarch-Str. 58, 48149, Münster, Germany. bohmm@uni-muenster.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|June 1, 2010
PubMed
Summary

Alpha-melanocyte-stimulating hormone (alpha-MSH) plays a key role in skin tanning and offers cytoprotective benefits. Its synthetic analogue, NDP-alpha-MSH, is being investigated for treating photodermatoses and inflammatory skin conditions.

More Related Videos

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

Related Experiment Videos

Last Updated: Jun 12, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
12:37

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model

Published on: September 7, 2013

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

Area of Science:

  • Dermatology and endocrinology, focusing on skin biology and therapeutic applications of peptide hormones.

Background:

  • Alpha-melanocyte-stimulating hormone (alpha-MSH) is a skin-derived peptide crucial for UV-induced tanning via melanocortin-1 receptor (MC-1R) activation.
  • alpha-MSH exhibits pigment-inducing and cytoprotective properties, making it a target for dermatological therapies.
  • Preclinical studies suggest alpha-MSH possesses significant anti-inflammatory and antifibrotic effects.

Purpose of the Study:

  • To evaluate the therapeutic potential of NDP-alpha-MSH, a potent alpha-MSH analogue, in patients with photodermatoses.
  • To explore the anti-inflammatory and antifibrotic properties of alpha-MSH analogues in clinical settings.
  • To investigate novel therapeutic strategies in dermatology, including truncated peptides like KDPT.

Main Methods:

  • Phase II clinical trials were conducted using subcutaneously administered NDP-alpha-MSH.
  • Preclinical studies investigated the anti-inflammatory and antifibrotic effects of alpha-MSH.
  • Emerging research focuses on truncated tripeptides (e.g., KDPT) as MC-1R-independent anti-inflammatory agents.

Main Results:

  • NDP-alpha-MSH has undergone initial clinical trials for photodermatoses like erythropoietic protoporphyria.
  • Preclinical data indicate promising anti-inflammatory and antifibrotic activities for alpha-MSH.
  • Truncated tripeptides are emerging as a novel therapeutic avenue for inflammatory skin conditions.

Conclusions:

  • NDP-alpha-MSH demonstrates potential as a therapeutic agent for photodermatoses and other skin conditions.
  • Further clinical studies are warranted to confirm the anti-inflammatory and antifibrotic benefits of alpha-MSH analogues.
  • Novel peptide-based therapies are advancing dermatological treatment options for inflammatory and fibrotic skin diseases.